Copyright 2013 American Medical Association. All Rights Reserved. Applicable
FARS/DFARS Restrictions Apply to Government Use.
To the Editor The Research Letter on patient preferences for deactivation of implantable cardioverter-defibrillators (ICDs) provides useful data that may help avoid some device-related dilemmas increasingly encountered in clinical practice.1 Patients often intuitively accept the evidence-based offer of ICD therapy to avoid the specter of sudden death without fully appreciating the consequences of that decision.
Beattie JM, Flynn TN, Clark AM. Patient Preferences for Deactivation of Implantable
Cardioverter-Defibrillators. JAMA Intern Med. 2013;173(16):1556-1557. doi:10.1001/jamainternmed.2013.8141